Investec Asset Management PTY Ltd grew its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,521 shares of the medical research company’s stock after buying an additional 443 shares during the period. Thermo Fisher Scientific comprises 1.3% of Investec Asset Management PTY Ltd’s portfolio, making the stock its 14th largest position. Investec Asset Management PTY Ltd’s holdings in Thermo Fisher Scientific were worth $2,537,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the business. Covington Capital Management lifted its holdings in shares of Thermo Fisher Scientific by 0.9% in the 2nd quarter. Covington Capital Management now owns 2,144 shares of the medical research company’s stock worth $374,000 after purchasing an additional 20 shares during the last quarter. Investment Centers of America Inc. lifted its holdings in shares of Thermo Fisher Scientific by 1.6% in the 2nd quarter. Investment Centers of America Inc. now owns 1,317 shares of the medical research company’s stock worth $230,000 after purchasing an additional 21 shares during the last quarter. Fort Washington Investment Advisors Inc. OH lifted its holdings in shares of Thermo Fisher Scientific by 0.4% in the 2nd quarter. Fort Washington Investment Advisors Inc. OH now owns 6,250 shares of the medical research company’s stock worth $1,090,000 after purchasing an additional 23 shares during the last quarter. Bienville Capital Management LLC lifted its holdings in shares of Thermo Fisher Scientific by 1.6% in the 2nd quarter. Bienville Capital Management LLC now owns 1,687 shares of the medical research company’s stock worth $295,000 after purchasing an additional 27 shares during the last quarter. Finally, Savant Capital LLC lifted its holdings in shares of Thermo Fisher Scientific by 1.0% in the 2nd quarter. Savant Capital LLC now owns 2,793 shares of the medical research company’s stock worth $487,000 after purchasing an additional 29 shares during the last quarter. 86.16% of the stock is currently owned by institutional investors.

In related news, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total value of $9,419,500.00. Following the sale, the chief executive officer now directly owns 252,577 shares in the company, valued at approximately $47,582,981.03. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.49% of the stock is owned by company insiders.

Several brokerages recently issued reports on TMO. Jefferies Group reissued a “hold” rating and issued a $195.00 price target on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 price target on the stock in a report on Thursday, September 7th. Leerink Swann reissued an “outperform” rating and issued a $200.00 price target (down previously from $216.00) on shares of Thermo Fisher Scientific in a report on Monday, December 4th. Argus reissued a “buy” rating on shares of Thermo Fisher Scientific in a report on Tuesday, August 22nd. They noted that the move was a valuation call. Finally, Morgan Stanley reissued an “overweight” rating and issued a $220.00 price target on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. One research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Thermo Fisher Scientific currently has an average rating of “Buy” and an average price target of $205.21.

Thermo Fisher Scientific Inc. (TMO) traded down $3.00 on Friday, reaching $188.32. The company had a trading volume of 2,158,700 shares, compared to its average volume of 1,565,293. Thermo Fisher Scientific Inc. has a 12-month low of $139.88 and a 12-month high of $201.20. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85. The firm has a market cap of $76,778.59, a PE ratio of 21.04, a P/E/G ratio of 1.75 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, beating the consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The firm had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.03 billion. During the same period last year, the firm earned $2.03 EPS. The firm’s revenue was up 13.9% compared to the same quarter last year. equities analysts predict that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be given a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.32%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

TRADEMARK VIOLATION WARNING: This story was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another website, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/12/15/thermo-fisher-scientific-inc-tmo-shares-bought-by-investec-asset-management-pty-ltd.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related stocks with our FREE daily email newsletter.